---
pmcid: PMC8398452
image_filename: pharmaceutics-13-01295-g004.jpg
figure_link: /pmc/articles/PMC8398452/figure/pharmaceutics-13-01295-f004/
number: Figure 4
figure_title: ''
caption: Schematic representation of some Ru-based drug candidates. Different Ru-complexes
  mediated CRC cells apoptosis through DNA damage (1a–d), inhibiting DNA topoisomerase
  II enzyme (2a–c), and regulating MAPK signaling pathway (3a–d).
article_title: 'Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal
  Cancer Treatment.'
citation: Kazi Mustafa Mahmud, et al. Pharmaceutics. 2021 Aug;13(8):1295.

doi: 10.3390/pharmaceutics13081295
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI

keywords:
- ruthenium
- nanoparticles
- colorectal cancer
- treatment
- diagnosis

---
